Douglas Roblin to Adrenergic beta-Antagonists
This is a "connection" page, showing publications Douglas Roblin has written about Adrenergic beta-Antagonists.
Connection Strength
0.077
-
A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction. Arch Intern Med. 2008 Mar 10; 168(5):477-83; discussion 483; quiz 447.
Score: 0.077